SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-006104
Filing Date
2020-03-12
Accepted
2020-03-12 15:44:15
Documents
98
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2019_xtlbiopharma.htm 20-F 1616116
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A), A f20f2019ex12-1_xtlbiopharma.htm EX-12.1 12142
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A), A f20f2019ex12-2_xtlbiopharma.htm EX-12.2 12281
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO f20f2019ex13-1_xtlbiopharma.htm EX-13.1 5402
5 GRAPHIC image_001.jpg GRAPHIC 5398
6 GRAPHIC image_002.jpg GRAPHIC 77364
  Complete submission text file 0001213900-20-006104.txt   5463404

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE xtlb-20191231.xml EX-101.INS 863727
8 XBRL SCHEMA FILE xtlb-20191231.xsd EX-101.SCH 91211
9 XBRL CALCULATION FILE xtlb-20191231_cal.xml EX-101.CAL 61665
10 XBRL DEFINITION FILE xtlb-20191231_def.xml EX-101.DEF 157668
11 XBRL LABEL FILE xtlb-20191231_lab.xml EX-101.LAB 404402
12 XBRL PRESENTATION FILE xtlb-20191231_pre.xml EX-101.PRE 286371
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-36000 | Film No.: 20708631
SIC: 2834 Pharmaceutical Preparations